^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Radiotron™

    Company:
    Geneseeq
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Radiotron™ is a 474-gene panel for all solid tumors that is upgraded from GeneseeqPrime™ 437-gene panel. It has a total of 106 genes associated with radiosensitivity, radiotherapy tolerance and susceptibility to radiation-induced second cancer.
    Cancer:
    Solid Tumor
    Method:
    Next-Generation Sequencing (NGS)